HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donatella Aldinucci Selected Research

CCR5 Receptors (CCR5 Receptor)

7/2020The CCL5/CCR5 Axis in Cancer Progression.
1/2019CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth.
5/2018Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.
1/2014The inflammatory chemokine CCL5 and cancer progression.
2/2008Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Donatella Aldinucci Research Topics

Disease

32Neoplasms (Cancer)
01/2022 - 02/2002
21Hodgkin Disease (Hodgkin's Disease)
05/2022 - 02/2002
5Ovarian Neoplasms (Ovarian Cancer)
08/2021 - 11/2014
5Prostatic Neoplasms (Prostate Cancer)
04/2019 - 01/2011
3Neoplasm Metastasis (Metastasis)
05/2018 - 01/2014
3Lymphoma (Lymphomas)
01/2014 - 03/2005
3Carcinoma (Carcinomatosis)
05/2013 - 03/2008
2Weight Loss (Weight Reduction)
01/2021 - 01/2019
2Hematologic Neoplasms (Hematological Malignancy)
07/2020 - 01/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2017 - 01/2017
2Inflammation (Inflammations)
01/2014 - 02/2012
2Starvation
05/2013 - 09/2002
2Necrosis
12/2012 - 03/2012
2Myeloid Leukemia (Leukemia, Myelocytic)
01/2008 - 03/2007
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2008 - 03/2007
2T-Cell Lymphoma (Lymphoma, T Cell)
03/2005 - 01/2004
2Leukemia
01/2004 - 11/2002
1Acquired Immunodeficiency Syndrome (AIDS)
07/2020
1Lymphadenitis (Adenitis)
02/2020
1Osteosarcoma (Osteogenic Sarcoma)
04/2019
1Pain (Aches)
06/2017
1Breast Neoplasms (Breast Cancer)
01/2017
1Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2013
1Adenocarcinoma
03/2005
1Fibrosis (Cirrhosis)
09/2004
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2004
1Multiple Myeloma
05/2002

Drug/Important Bio-Agent (IBA)

13Cisplatin (Platino)FDA LinkGeneric
08/2021 - 03/2005
9Pharmaceutical PreparationsIBA
05/2022 - 01/2011
7GoldIBA
04/2019 - 03/2007
6CytokinesIBA
01/2016 - 02/2002
5Doxorubicin (Adriamycin)FDA LinkGeneric
08/2021 - 11/2014
5CCR5 Receptors (CCR5 Receptor)IBA
07/2020 - 02/2008
5ChemokinesIBA
07/2020 - 03/2005
5Interferon Regulatory FactorsIBA
01/2014 - 05/2002
4LigandsIBA
07/2020 - 08/2011
4Biological ProductsIBA
07/2014 - 05/2002
4Antineoplastic Agents (Antineoplastics)IBA
07/2014 - 03/2005
4CD40 Ligand (CD40L)IBA
02/2012 - 11/2002
3MaravirocFDA Link
01/2022 - 01/2019
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2021 - 03/2008
3Conditioned Culture MediaIBA
02/2020 - 05/2013
3Chemokine CCL5IBA
05/2018 - 02/2008
3PlatinumIBA
11/2014 - 03/2005
3peptide permeaseIBA
07/2014 - 03/2012
3PeptidomimeticsIBA
07/2014 - 03/2012
3Stem Cell FactorIBA
03/2005 - 09/2002
3Interleukin-3 (Interleukin 3)IBA
03/2005 - 02/2002
3Interleukin-9 (Interleukin 9)IBA
03/2005 - 02/2002
2TrabectedinIBA
01/2022 - 01/2021
2Paclitaxel (Taxol)FDA LinkGeneric
03/2021 - 04/2020
2CC ChemokinesIBA
07/2020 - 05/2018
2Brentuximab VedotinIBA
02/2020 - 01/2019
2SuspensionsIBA
02/2020 - 11/2014
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
06/2017 - 03/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2017 - 03/2008
2Interleukin-6 (Interleukin 6)IBA
06/2017 - 09/2009
2lipoplatinIBA
11/2014 - 12/2013
2ErbB Receptors (EGF Receptor)IBA
05/2013 - 08/2011
2Proteins (Proteins, Gene)FDA Link
03/2008 - 01/2004
2Cytostatic AgentsIBA
01/2008 - 03/2007
1PhosphatidylserinesIBA
08/2021
1PeptaibolsIBA
08/2021
1Epidermal Growth Factor (EGF)IBA
03/2021
1Carboplatin (JM8)FDA LinkGeneric
03/2021
1Monoclonal AntibodiesIBA
07/2020
1Tissue Inhibitor of Metalloproteinase-3IBA
02/2020
1Thioredoxin-Disulfide ReductaseIBA
04/2019
1Proteasome Endopeptidase Complex (Proteasome)IBA
04/2019
1Interleukin-10 (Interleukin 10)IBA
01/2019
1Etoposide (VP 16)FDA LinkGeneric
09/2017
1Endothelial Growth FactorsIBA
09/2017
1Bevacizumab (Avastin)FDA Link
09/2017
1Zoledronic Acid (Zometa)FDA Link
06/2017
1Gold CompoundsIBA
01/2017
1Auranofin (Ridaura)FDA Link
09/2015
1Albumin-Bound PaclitaxelFDA Link
11/2014
1Caspase 9IBA
11/2014
1Bortezomib (Velcade)FDA Link
01/2014
1Proteasome InhibitorsIBA
01/2014
1Gefitinib (Iressa)FDA Link
05/2013
1Docetaxel (Taxotere)FDA Link
05/2013
1Tyrosine Kinase InhibitorsIBA
05/2013
1Sarcosine (Methylglycine)IBA
12/2012
12-aminoisobutyric acidIBA
12/2012
1MetalsIBA
12/2012
1OligopeptidesIBA
12/2012
1Methoxychlor (Metox)IBA
01/2011
1AndrogensIBA
01/2011
1Chemokine ReceptorsIBA
01/2010
1Interleukin-7 (Interleukin 7)IBA
09/2009
1InterleukinsIBA
09/2009
1Interleukin-8 (Interleukin 8)IBA
03/2008
1Pentostatin (Nipent)FDA LinkGeneric
03/2005
1Interleukin-13IBA
09/2004
1Transforming Growth Factor beta (TGF-beta)IBA
09/2004
1Messenger RNA (mRNA)IBA
01/2004
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2004

Therapy/Procedure

4Drug Therapy (Chemotherapy)
03/2021 - 12/2013
1Radiotherapy
09/2017